Back to OVID

GOLDMAN SACHS GROUP INC → OVID

GOLDMAN SACHS GROUP INC OVID Position History

Ovid Therapeutics Inc. • Healthcare

Quarters held
12
Latest value
$850K
Q3 2026
Peak value
$850K
First seen
Q1 2025

Dollar value over time

Show data table
PeriodPosition value
Q1 2025$27K
Q1 2025$6K
Q2 2025$88K
Q2 2025$5K
Q3 2025$37K
Q4 2025$278K
Q4 2025$278K
Q1 2026$339K
Q2 2026$308K
Q2 2026$587K
Q3 2026$680K
Q3 2026$850K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$850K341.4K——
Q3 2026$680K273.0K——
Q2 2026$587K218.3K——
Q2 2026$308K114.4K——
Q1 2026$339K152.8K——
Q4 2025$278K170.5K——
Q4 2025$278K170.5K——
Q3 2025$37K28.5K——
Q2 2025$5K15.7K——
Q2 2025$88K268.2K——
Q1 2025$6K18.1K——
Q1 2025$27K86.3K——

Other funds holding OVID

Other GOLDMAN SACHS GROUP INC positions

NVDA

NVIDIA CORPORATION

$37B
AAPL

APPLE INC

$31.7B
NVDA

NVIDIA CORPORATION

$31.3B
NVDA

NVIDIA CORPORATION

$27.9B
NVDA

NVIDIA CORPORATION

$27.9B
NVDA

NVIDIA CORPORATION

$27.3B
AAPL

APPLE INC

$26.9B
NVDA

NVIDIA CORPORATION

$26.5B